APA

Xu L., Stevens J., Hilton M. B., Seaman S., Conrads T. P., Veenstra T. D., Logsdon D., Morris H., Swing D. A., Patel N. L., Kalen J., Haines D. C., Zudaire E. & St Croix B. (20150219). COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. : Science translational medicine.

Chicago

Xu Lihong, Stevens Janine, Hilton Mary Beth, Seaman Steven, Conrads Thomas P, Veenstra Timothy D, Logsdon Daniel, Morris Holly, Swing Deborah A, Patel Nimit L, Kalen Joseph, Haines Diana C, Zudaire Enrique and St Croix Brad. 20150219. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. : Science translational medicine.

Harvard

Xu L., Stevens J., Hilton M. B., Seaman S., Conrads T. P., Veenstra T. D., Logsdon D., Morris H., Swing D. A., Patel N. L., Kalen J., Haines D. C., Zudaire E. and St Croix B. (20150219). COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. : Science translational medicine.

MLA

Xu Lihong, Stevens Janine, Hilton Mary Beth, Seaman Steven, Conrads Thomas P, Veenstra Timothy D, Logsdon Daniel, Morris Holly, Swing Deborah A, Patel Nimit L, Kalen Joseph, Haines Diana C, Zudaire Enrique and St Croix Brad. COX-2 inhibition potentiates antiangiogenic cancer therapy and prevents metastasis in preclinical models. : Science translational medicine. 20150219.